About Index Trending news
Analyze
Top 50 Pricing
Arrogene

Arrogene

Work at Arrogene? Add yourself to this profile

Arrogene

Arrogene, Inc. is working on building a pipeline of new generation nanomedicines capable of targeting cancer cells and specifically preventing tumor growth.

Elsewhere

Alexa global traffic share

Latest funding
Debt financing
$750,000
Debt financing
$250,000
Employees

Unknown size

Locations

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Arrogene makes some noise.